Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

J B Gordon, P Ganz, E G Nabel, R D Fish, J Zebede, G H Mudge, R W Alexander, A P Selwyn, J B Gordon, P Ganz, E G Nabel, R D Fish, J Zebede, G H Mudge, R W Alexander, A P Selwyn

Abstract

We studied the vasomotion of epicardial coronary arteries during exercise and tested the hypotheses that abnormal vasoconstriction is related to the presence of atherosclerosis and may be related to endothelial dilator dysfunction. During cardiac catheterization quantitative coronary angiography was performed in 21 patients during supine bicycle exercise. 21 of 28 smooth, angiographically normal vessel segments dilated (14.0 +/- 1.8%) during exercise; four smooth segments did not change whereas only three constricted. In contrast, 15 of 16 vessel segments with irregularities constricted in response to exercise (17.0 +/- 0.1%) with only one segment dilating. All 10 stenotic segments constricted to exercise (23 +/- 4%). Six patients also received intracoronary acetylcholine before exercise to test endothelium-dependent dilator function. In five of six patients all nine vessel segments showed the same directional response to acetylcholine and exercise. Three irregular and two stenotic segments constricted with acetylcholine (51 +/- 21%) and exercise (9.0 +/- 0.6%). In contrast, four smooth segments dilated to acetylcholine (19 +/- 6%) and exercise (9 +/- 1%). Both exercise and acetylcholine generally dilated smooth but constricted irregular and stenosed coronary segments. It appears likely that atherosclerosis plays an important role in the abnormal vasomotion of diseased coronary arteries during exercise and the pattern of abnormality suggests impairment of vasodilator function.

References

    1. Circulation. 1971 Aug;44(2):181-95
    1. Life Sci. 1977 Sep 1;21(5):625-36
    1. Am J Cardiol. 1977 Oct;40(4):487-91
    1. Nature. 1980 Nov 27;288(5789):373-6
    1. Circ Res. 1982 Jul;51(1):56-66
    1. Circulation. 1983 Aug;68(2):453-61
    1. Science. 1983 Aug 5;221(4610):560-2
    1. Nature. 1983 Oct 13-19;305(5935):627-30
    1. Circ Res. 1983 Nov;53(5):557-73
    1. Circ Res. 1984 Jan;54(1):50-7
    1. Circ Res. 1984 Jun;54(6):711-8
    1. Circulation. 1984 Dec;70(6):917-22
    1. Am J Cardiol. 1984 Dec 1;54(10):1195-200
    1. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1161-9
    1. Basic Res Cardiol. 1985 Sep-Oct;80(5):475-90
    1. Hypertension. 1986 Jan;8(1):37-44
    1. Am J Cardiol. 1986 Apr 15;57(11):984-9
    1. Circulation. 1986 May;73(5):865-76
    1. Circ Res. 1986 Jun;58(6):783-9
    1. N Engl J Med. 1986 Oct 23;315(17):1046-51
    1. Eur J Pharmacol. 1986 Sep 9;128(3):277-81
    1. J Clin Invest. 1987 Jan;79(1):170-4
    1. J Am Coll Cardiol. 1987 Aug;10(2):311-3
    1. Circulation. 1988 Jan;77(1):43-52
    1. J Clin Invest. 1988 Jan;81(1):21-31

Source: PubMed

3
订阅